| Half-life | 25 hours |
| Clearance Route | hepatic |
| Active Metabolites | no |
| Notes | Dose limiting toxicity is bone marrow suppression. |
Severity: Severe
Adverse Effects:
Myelosuppression, hair loss, nausea/vomiting
Contraindications:
Severe neutropenia
Precautions:
Monitor CBC weekly; avoid intrathecal administration.